Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LANTHEUS HOLDINGS, INC.

(LNTH)
  Report
Delayed Nasdaq  -  04:00 2022-12-07 pm EST
54.33 USD   -2.07%
12/06Lantheus Holdings Prices $500 Million Convertible Senior Notes Offering
MT
12/06Lantheus Holdings, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
12/06Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about LANTHEUS HOLDINGS, INC.
12/06Lantheus Holdings Prices $500 Million Convertible Senior Notes Offering
MT
12/06Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senio..
GL
12/05Sector Update: Healthcare Stocks Slide Monday but Outperform Most Sectors
MT
12/05Sector Update: Health Care Stocks Pulled Lower by Sinking Biotechs
MT
12/05Lantheus Holdings Shares Drop 10% After Planned Senior Notes Offering
DJ
12/05Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday
MT
12/05Lantheus Holdings Plans to Offer $500 Million of Convertible Notes
MT
12/05Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior ..
GL
12/05Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior ..
AQ
11/29Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial
GL
11/29Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial
GL
11/29Lantheus Holdings, Inc. Appoints Amanda Morgan as Senior Vice President, Commercial
CI
11/28Lantheus Holdings Secures Chinese Approval for Ultrasound Enhancing Agent
MT
11/28Lantheus Announces the Approval of DEFINITY« (Perflutren Lipid Microsphere) by China's ..
GL
11/28Lantheus Announces the Approval of DEFINITY« (Perflutren Lipid Microsphere) by China's ..
AQ
11/28Lantheus Announces the Approval of DEFINITY« (Perflutren Lipid Microsphere) by China..
CI
11/14POINT Biopharma Global Posts Wider Q3 Loss, Signs License Agreements With Lantheus; Sha..
MT
11/14Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agr..
GL
11/14Lantheus and Point Biopharma Announces Strategic Collaboration and Exclusive License Ag..
CI
11/10Insider Sell: Lantheus Holdings
MT
11/09Lantheus to Present at the Jefferies London Healthcare Conference
GL
11/03Transcript : Lantheus Holdings, Inc., Q3 2022 Earnings Call, Nov 03, 2022
CI
11/03Lantheus : Reports Third Quarter 2022 Financial Results - Form 8-K
PU
11/03Lantheus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
11/03Lantheus Holdings : Q3 Earnings Snapshot
AQ
11/03Lantheus : Q3 2022 Reconciliation of GAAP to Non-GAAP Financial Measures
PU
11/03GUIDANCE: (LNTH) LANTHEUS HOLDINGS Expects Q4 EPS Range $0.95 - $0.98
MT
11/03Earnings Flash (LNTH) LANTHEUS HOLDINGS Posts Q3 Revenue $239.3M
MT
11/03Earnings Flash (LNTH) LANTHEUS HOLDINGS Posts Q3 EPS $0.99
MT
11/03Lantheus Reports Third Quarter 2022 Financial Results
GL
11/03Lantheus Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter 2022
CI
11/03Lantheus Holdings, Inc. Raises Revenue Guidance for the Full Year of 2022
CI
10/20Insider Sell: Lantheus Holdings
MT
10/20Insider Sell: Lantheus Holdings
MT
10/20Lantheus To Host Third Quarter 2022 : 00 a.m. Eastern Time
GL
10/17Lantheus Presentations at the European Association of Nuclear Medicine Annual Meeting S..
GL
10/13Mizuho Securities Starts Lantheus Holdings at Buy With $105 Price Target
MT
10/12Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from S&P..
CI
10/12Lantheus Holdings, Inc.(NasdaqGM:LNTH) added to S&P 400..
CI
10/12Lantheus Holdings, Inc.(NasdaqGM:LNTH) dropped from S&P..
CI
10/12Lantheus Holdings, Inc.(NasdaqGM:LNTH) added to S&P 400
CI
10/07Lantheus Holdings Shares Fall Despite Addition to S&P MidCap 400
MT
10/07JonesTrading Starts Lantheus Holdings at Buy With $104 Price Target
MT
10/06Targa Resources to Join S&P 500; Lantheus to Join S&P MidCap 400; Payoneer to Join S&P ..
MT
09/13Lantheus, GE Healthcare Say Study Shows 18F flurpiridaz PET Radiotracer Can Improve Cor..
MT
09/13GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotra..
GL
09/13GE Healthcare and Lantheus Phase III Clinical Trial Finds flurpiridaz PET Radiotracer C..
AQ
09/13GE Healthcare and Lantheus Holdings Inc Announces Phase III Clinical Trial Finds [╣8F]f..
CI
09/13GE, Lantheus Say Heart Disease Tracer Trial Met Key Endpoints
DJ
09/08Insider Sell: Lantheus Holdings
MT
09/08Insider Sell: Lantheus Holdings
MT
09/01Lantheus to Present at the Wells Fargo Healthcare Conference
GL
08/25Lantheus Holdings Shares Rise After B. Riley Resumes Coverage
MT
08/25B. Riley Securities Resumes Lantheus Holdings at Buy with $102 PT, Views as 'Best Posit..
MT
08/22Insider Sell: Lantheus Holdings
MT
08/15Insider Sell: Lantheus Holdings
MT
08/11Insider Sell: Lantheus Holdings
MT
08/05SVB Securities Raises Lantheus Holdings Price Target to $110 From $100, Maintains Outpe..
MT
08/04Lantheus Reports Increase in Q2 Adjusted Net Income, Revenue; Raises 2022 Targets
MT
08/04Lantheus Holdings to Seek Acquisitions
CI
08/04Transcript : Lantheus Holdings, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Lantheus : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/04Lantheus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months ..
CI
08/04Lantheus Holdings : Q2 Earnings Snapshot
AQ
08/04Lantheus : Q2 2022 Reconciliation of GAAP to Non-GAAP Financial Measures
PU
08/04Lantheus Reports Second Quarter 2022 Financial Results
GL
08/04GUIDANCE: (LNTH) LANTHEUS HOLDINGS Sees Q3 EPS Range $0.80 - $0.85
MT
08/04Lantheus Reports Second Quarter 2022 Financial Results
AQ
08/04GUIDANCE: (LNTH) LANTHEUS HOLDINGS Sees Fiscal Year 2022 EPS Range $3.50 - $3.6..
MT
08/04Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q2 Revenue $223.7M
MT
08/04Earnings Flash (LNTH) LANTHEUS HOLDINGS Posts Q2 EPS $0.89
MT
08/04Lantheus Holdings, Inc. Updates Earnings Guidance for the Full Year 2022
CI
08/04Lantheus Holdings, Inc. Provides Earnings Guidance for the Third Quarter 2022
CI
08/04Radiopharm Theranostics Enters Strategic Collaboration, Acquires Rights for Nanobody Im..
MT
08/03Radiopharm Theranostics Enters Collaboration Agreement with Lantheus for the Mutually B..
CI
1  2  3  4  5  6  7  8  9Next
Upcoming event on LANTHEUS HOLDINGS, INC.